Genmab — December 2019
-
https://www.researchgate.net/profile/Pieternella_Lugtenburg Hende her fra Erasmus er en af eksperterne. Erasmus var første sted CD20xCD3 blev afprøvet i mennesker. Hun er i hvert tilfælde ekspert indenfor området og har været med på mange artikler om stoffer fra andre pharma. Bl.a. fra Roche som sidder på en stor del af B-celle markedet.
-
Husk at patienterne i CD20xCD3 er: Relapsed, progressive and/or refractory disease following treatment with an anti-CD20 monoclonal antibody (e.g. rituximab) potentially in combination with chemotherapy and/or relapsed after autologous stem cell rescue
-
Jeg har lavet denne gruppe til formålet: https://www.facebook.com/search/top/?q=aktiebaren&epa=SEARCH_BOX
-
-
-
-
-
Tak Solsen, lyder super godt
-
And thanks EL
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind